Antidepressant treatment reduces Fos-like immunoreactivity induced by swim stress in different columns of the periaqueductal gray matter

Brain Research Bulletin

Volumn 70, Issue 4-6, 2006, Pages 414-421

  Lino de Oliveira, Cilene ^a   de Oliveira, Rúbia M W ^b   Pádua Carobrez, Antonio ^a   de Lima, Thereza C M ^a   Bel, Elaine Aparecida Del ^c   Guimarães, Francisco Silveira ^d  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b STATE UNIVERSITY OF MARINGÁ   (Brazil)

^c FORP   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aversion; c fos; Depression; Immunohistochemistry; Uncontrollable stress

Indexed keywords

ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DESIPRAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLIMBING; CONTROLLED STUDY; DRUG EFFECT; HYPOTHALAMUS NUCLEUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LATERAL GENICULATE BODY; MALE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; SCORING SYSTEM; STRESS; SWIMMING; THALAMUS VENTRAL NUCLEUS;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; CELL COUNT; CLOMIPRAMINE; DESIPRAMINE; DISEASE MODELS, ANIMAL; IMMOBILITY RESPONSE, TONIC; MALE; ONCOGENE PROTEINS V-FOS; PERIAQUEDUCTAL GRAY; RATS; RATS, WISTAR; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 33749240000     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2006.07.007     Document Type: Article

References (33)

1. Bandler R., and Depaulis A. Midbrain periaqueductal gray control of defensive behavior in the cat and in the rat. In: Depaulis A., and Bandler R. (Eds). The midbrain periaqueductal gray matter: functional, anatomical and neurochemical organization (1991), Plenum Press, New York 175-198
2. Bellchambers C.E., Chieng B., Keay K.A., and Christie M.J. Swim-stress but not opioid withdrawal increases expression of c-fos immunoreactivity in rat periaqueductal gray neurons which project to the rostral ventromedial medulla. Neuroscience 83 (1998) 517-524
3. Bing G., Stone E.A., Zangh Y., and Filer D. Immunohistochemical studies of noradrenergic-induced expression of c-fos in the rat CNS. Brain Res. 592 (1992) 57-62
4. Brandão M.L., Lopez-Garcia J.A., Graeff F.G., and Roberts M.H.T. Electrophysiological evidence for excitatory 5-HT2 and depressant 5-HT1a receptors on neurones of the rat midbrain tectum. Brain Res. 556 (1991) 259-266
5. Campeau S., and Watson S.J. Neuroendocrine and behavioral responses and brain pattern of c-fos induction associated with audiogenic stress. J. Neuroendocrinol. 9 (1997) 577-588
6. Canteras N.S., and Goto M. Fos-like immunoreactivity in the periaqueductal gray of rats exposed to a natural predator. Neuroreport 10 (1999) 413-418
7. Carobrez A.P., Teixeira K.V., and Graeff F.G. Modulation of defensive behavior by periaqueductal gray NMDA/glycine-B receptor. Neurosci. Biobehav. Rev. 25 (2001) 697-709
8. Carrive P., and Bandler R. Viscerotopic organization of neurons subserving hypotensive reactions within the midbrain periaqueductal gray: a correlative functional and anatomical study. Brain Res. 541 (1991) 206-215
9. Chung K.K.K., Martinez M., and Herbert J. c-fos expression, behavioral, endocrine and autonomic responses to acute social stress in male rats after chronic restraint: modulation by serotonin. Neuroscience 95 (1999) 453-463
10. Compaan C.J., Groenick L., Van der Gugten J., Maes A.A.R., and Olivier B. Pretreatment with 5HT1a receptor agonist flesinoxan attenuates Fos protein in rat hypothalamus. Eur. J. Pharmacol. 324 (1997) 161-168
11. Cryan J.F., Page M.E., and Lucki I. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology 182 (2005) 335-344
12. Detke M.J., Rickels M., and Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121 (1995) 66-72
13. Duncan G.E., Knapp D.J., Johnson K.B., and Breese G.R. Functional classification of antidepressants based on antagonism of swim stress-induced Fos-like immunoreactivity. J. Pharmacol. Exp. Ther. 277 (1996) 1076-2089
14. Keay K.A., and Bandler R. Parallel circuits mediating distinct emotional coping reactions to different types of stress. Neurosci. Biobehav. Rev. 25 (2001) 669-678
15. Keay K.A., Clement C.I., Depaulis A., and Bandler R. Different representations of inescapable noxious stimuli in the periaqueductal gray and upper cervical spinal cord of freely moving rats. Neurosci. Lett. 313 (2001) 17-20
16. Lino-de-Oliveira C., De Lima T.C.M., and Carobrez A.P. Dorsal periaqueductal gray matter inhibits passive coping strategy elicited by forced swimming stress in rats. Neurosci. Lett. 335 (2002) 87-90
17. Lino-de-Oliveira C., De Lima T.C.M., and Carobrez A.P. Structure of the rat behaviour in the forced swimming test. Behav. Brain Res. 158 (2005) 243-250
18. Lino-de-Oliveira C., Sales A.J., Del Bel E.A., Silveira M.C.L., and Guimarães F.S. Effects of acute and chronic fluoxetine treatments on restraint stress-induced Fos expression. Brain Res. Bull. 55 (2001) 747-754
19. Lovick T. Influence of dorsal and median raphe nuclei on neurons in the periaqueductal gray matter: role of 5-hydroxitryptamine. Neuroscience 59 (1994) 993-1000
20. Melia K.R., Ryabinin A.E., Schroeder R., Bloom F.E., and Wilson M.C. Induction and habituation of immediate early gene expression in rat brain by acute and repeated restraint stress. J. Neurosci. 14 (1994) 5929-5938
21. Mongeau R., Blier P., and de Montigny C. The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res. Rev. 23 (1997) 145-195
22. Morgan J.I., and Curran T. Proto-oncogenes: beyond second messengers. In: Bloom F.E., and Kupfer D.J. (Eds). Psychopharmacology: the fourth generation of progress (1995), Raven Press, New York 631-642
23. Paul I.A., Duncan G.E., Powell K.R., Mueller R.A., Hong J.S., and Breese G.R. Regionally specific neural adaptation of beta adrenergic and 5-hydroxytryptamine 2 receptors after antidepressant administration in the forced swim test and after chronic antidepressant drug treatment. J. Pharmacol. Exp. Ther. 246 3 (1988) 956-962
24. Paxinos G., and Watson C. Stereotaxic Atlas of the Rat Brain. 4th ed. (1998), Academic Press, New York
25. Peroutka S.J., and Snyder S.H. Long term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210 (1980) 88-90
26. Porsolt L.D., Anton G., Blavet N., and Jalfre M. Behavioral despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47 (1978) 379-391
27. Post R.M. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am. J. Psychiatry 149 (1992) 999-1010
28. Richelson E., and Pfenning M. Blockade of antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur. J. Pharmacol. 104 (1984) 277-286
29. Schenberg L.C., Bittencourt A.S., Sudré E.C.M., and Vargas L.C. Modelling panic attacks. Neurosci. Biobehav. Rev. 25 (2001) 647-659
30. Tilakaratne N., and Friedman E. Genomic response to 5-HT1A or 5-HT2a/2c receptor activation is differentially regulated in four regions of rat brain. Eur. J. Pharmacol. 307 (1996) 211-217
31. Tilakaratne N., Yang Z., and Friedman E. Chronic fluoxetine or desmethylimipramine treatment alters 5-HT2 receptor mediated c-fos gene expression. Eur. J. Pharmacol. 15 (1995) 263-266
32. Vaughan C.W., Bandler R., and Christie M.J. Differential response of lateral and ventrolateral rat periaqueductal gray neurones to noradrenaline in vitro. J. Physiol. 492 (1996) 373-381
33. Zanoveli J.M., Nogueira R.L., and Zangrossi Jr. H. Serotonin in the dorsal periaqueductal gray modulates inhibitory avoidance and one-way escape behaviors in the elevated T-maze. Eur. J. Pharmacol. 473 (2003) 153-161